动静脉瘘与移植物出血的急诊管理评估
该回顾性研究分析了2014至2022年间一家三级中心急诊科收治的66例动静脉通路出血患者,评估其表现、严重程度、管理及结局。结果显示超过三分之一的出血为危及生命或高风险,近半数需通路干预,1年内22.7%需新建通路,且6个月外科随访率仅45.5%。
要点
- 急诊AV通路出血中危及生命或高风险者占37.9%,需迅速评估。
- 48.5%的病例需血管外科会诊,会诊可减少相关再入院和1年干预。
- 1年内22.7%患者需新建AV通路,6个月随访率低(45.5%)。
核心结论
- 超过三分之一的AV通路出血急诊病例为危及生命或高风险。
- 许多患者1年内需要新建AV通路。
- 改善跨科室沟通和密切随访是改善结局的机会。
研究设计与样本
- 回顾性分析2014至2022年一家三级中心急诊科因AV通路出血就诊的患者。
- 共纳入66例患者,平均年龄65.4岁,51.5%为男性,66.7%为黑人,18.2%为西班牙裔。
主要发现
- 通路类型包括头臂(34.8%)、肱基底(28.8%)、桡头(9.1%)瘘,上肢AV移植物(16.7%)和下肢通路(16.7%)。
- 78.8%为穿刺后出血,18.2%为原发性溃疡。
- 急诊干预包括手动压迫(37.9%)、缝合(25.8%)、局部止血剂(15.2%)、夹闭装置(13.6%)和止血带(1.5%)。
- 59%患者从急诊出院,41%住院,住院者中15.2%放置隧道透析导管。
- 45.5%患者需要通路干预(45.5%开放手术,54.6%血管内),开放手术中60%为通路修复,40%为结扎。
临床怎么用
- 急诊AV通路出血应快速评估严重程度,高危患者需及时会诊血管外科。
- 通路外科医生参与急诊评估可能减少相关再入院和后续干预。
- 需加强患者随访以提高6个月随访率。
局限性
- 回顾性单中心研究,样本量较小(66例)。
- 随访率低可能影响结局评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arteriovenous (AV) access bleeding requires prompt management, but little is known about short- and long-term outcomes after these events. Our goal was to evaluate emergency management of AV access bleeds and their outcomes. METHODS: This is a retrospective analysis of emergency department (ED) visits for AV access bleeding at a tertiary care center between 2014 and 2022. Presentation, severity, management, and outcomes were evaluated. RESULTS: There were 66 patients that met the inclusion criteria (mean age was 65.4 years, 51.5% were male, 66.7% were Black, and 18.2% were Hispanic). Access types included brachiocephalic (34.8%), brachiobasilic (28.8%), radiocephalic (9.1%) fistulas, upper extremity AV grafts (16.7%), and lower extremity access (16.7%). The majority (78.8%) were postcannulation bleeds with 18.2% being primary ulcers. Triage emergency severity index classified ED presentation as life-threatening (6.1%), high-risk (31.8%), urgent (60.6%), and semi-urgent (1.5%). ED interventions included manual pressure (37.9%), suture placement (25.8%), topical hemostatic agents (15.2%), a clamp device (13.6%), and tourniquet placement (1.5%). Vascular surgery was consulted in approximately half (48.5%) of cases. In total, 59% of patients were discharged from the ED and 41% of patients were admitted to the hospital for further management. Tunneled dialysis catheters were placed in 15.2% of all hospitalized patients. In total, 45.5% of patients required an intervention on their access (45.5% open and 54.6% endovascular). In total, 60% and 40% of open operations were access revisions and ligations, respectively. The majority (83.3%) of patients undergoing fistulograms required an intervention. At 90 days, 59% of patients represented to the ED, with 23% of all readmissions for related causes. At 1 year, 22.7% of patients required new AV access creation. Six-month follow-up with an access surgeon was low at only 45.5% of patients. Having an access surgeon evaluate patients in the ED resulted in fewer related readmissions (25% vs. 2.9%, P = 0.02) and 1-year interventions (43.8% vs. 17.7%, P = 0.02), but there was no difference in the need for new AV access creations (12.5% vs. 2.9%, P = 0.19), and the 6-month follow-up in both groups was low (34.4% vs 55.9%, P = 0.08). CONCLUSION: Over one-third of AV access bleeds presenting to the ED were of life-threatening or high-risk severity. Many such patients required a new AV access within 1 year. Improved interdepartmental communication and close patient follow-up remain opportunities for improved outcomes.
引用
- Alonso A, Blum J, Frausto S, et al. Evaluating the Emergency Management of Arteriovenous Fistula and Graft Bleeds. Ann Vasc Surg. 2025. PMID: 40818818. doi:10.1016/j.avsg.2025.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。